AngioDynamics ANGO EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from AngioDynamics’s reported figures.
Based on trailing twelve months.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's EBITDA margin?
- AngioDynamics (ANGO) reported EBITDA margin of -3.9% in Q4 2025.
- How has AngioDynamics's EBITDA margin changed year-over-year?
- AngioDynamics's EBITDA margin increased by 49.0% year-over-year, from -7.7% to -3.9%.
- What is the long-term trend for AngioDynamics's EBITDA margin?
- Over 4 years (2021 to 2025), AngioDynamics's EBITDA margin has grown at a 10.7% compound annual growth rate (CAGR), from -3.2% to -4.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.